Loading...
XNYS
STE
Market cap25bUSD
Dec 04, Last price  
261.02USD
1D
0.62%
1Q
6.41%
Jan 2017
287.33%
IPO
245.68%
Name

STERIS plc

Chart & Performance

D1W1MN
XNYS:STE chart
P/E
41.78
P/S
4.70
EPS
6.25
Div Yield, %
0.62%
Shrs. gr., 5y
2.96%
Rev. gr., 5y
12.49%
Revenues
5.46b
+6.24%
1,160,285,0001,197,407,0001,265,090,0001,298,525,0001,257,733,0001,207,448,0001,391,504,0001,501,902,0001,622,252,0001,850,263,0002,238,764,0002,612,756,0002,619,996,0002,782,170,0003,030,895,0003,107,519,0004,585,064,0004,957,839,0005,138,701,0005,459,515,000
Net income
615m
+62.50%
70,289,00082,155,00077,106,000110,685,000128,467,00051,265,000136,115,000159,977,000129,442,000135,064,000110,763,000109,965,000290,915,000304,051,000407,659,000397,400,000243,888,000107,030,000378,239,000614,641,000
CFO
1.15b
+17.96%
161,955,00095,740,000143,401,000167,384,000224,954,000117,744,000149,372,000227,815,000209,631,000246,040,000254,675,000424,086,000457,632,000539,505,000590,559,000689,640,000684,811,000756,947,000973,274,0001,148,087,000
Dividend
Sep 05, 20240.57 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

STERIS plc provides infection prevention and other procedural products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and powered dental instruments, infection control products, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.
IPO date
Nov 03, 2015
Employees
17,000
Domiciled in
IE
Incorporated in
IE

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT